Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Condition: Triple Negative Breast Cancer Interventions: Drug: Gemcitabine and carboplatin plus antibiotic (moxifloxacin); Drug: Gemcitabine combined with carboplatin plus placebo Sponsor: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avelox | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Moxifloxacin | Research